GlassScriptPhysician profile
Ann Cheri Foxx
NPI 1639110455
$1,106.45
in general payments reported to CMS, 2019-2025
12 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $256 · 2021: $38.97 · 2022: $163 · 2023: $60.66 · 2024: $73.36 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337 · Travel and Lodging: $36.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.93 |
| Travel and Lodging | $36.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $766.11 | 2019-2024 | Senza, Vyrsa V1 |
| Abbott Laboratories | $84.17 | 2025 | Eterna |
| Nuvasive, INC. | $48.45 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.84 | 2025 | Xifaxan |
| Averitas Pharma INC. | $31.55 | 2025 | Qutenza |
| Axsome Therapeutics, INC. | $26.97 | 2025 | Auvelity |
| Ferring Pharmaceuticals INC. | $25.25 | 2021 | |
| Nalu Medical, INC. | $23.95 | 2025 | Nalu Neurostimulation System |
| Edwards Lifesciences Corporation | $20.48 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $15.98 | 2025 | General - Pain Management |
| Djo, LLC | $13.98 | 2020 | |
| Orthofix Medical, INC. | $13.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Foxx listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.